用于改善非小细胞肺癌临床决策的快速生物标志物检测 - Suppr | 超能文献

Rapid biomarker testing for improved clinical decision-making in nonsmall cell lung cancer.

作者信息

Kaplan Edward H

出版信息

MLO Med Lab Obs. 2017 Jun;49(6):12-4, 16-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Rapid biomarker testing for improved clinical decision-making in nonsmall cell lung cancer.用于改善非小细胞肺癌临床决策的快速生物标志物检测

MLO Med Lab Obs. 2017 Jun;49(6):12-4, 16-8.

2

Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable.非小细胞肺癌生物标志物检测的最新进展：来自国家肺癌圆桌会议的考量

J Thorac Oncol. 2019 Mar;14(3):338-342. doi: 10.1016/j.jtho.2019.01.002. Epub 2019 Jan 30.

3

Biomarker testing in non-small cell lung cancer: to move forward with quality.非小细胞肺癌中的生物标志物检测：迈向高质量发展。

Clin Transl Oncol. 2012 May;14(5):321-2. doi: 10.1007/s12094-012-0802-6.

4

[Non-small cell lung cancer. New biomarkers for diagnostics and therapy].[非小细胞肺癌。用于诊断和治疗的新型生物标志物]

Pathologe. 2015 Nov;36 Suppl 2:189-93. doi: 10.1007/s00292-015-0084-1.

5

Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer?我们是否有标志物来选择非小细胞肺癌的辅助治疗患者？

Ann Oncol. 2010 Oct;21 Suppl 7:vii199-202. doi: 10.1093/annonc/mdq452.

6

[Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].[非小细胞肺癌的诊断、预后及预测。形态学、免疫组织化学和分子病理学的重要性]

Pathologe. 2015 Nov;36 Suppl 2:194-200. doi: 10.1007/s00292-015-0085-0.

7

KRAS mutation spectrum notably diverges between non-small cell lung and colorectal carcinomas.KRAS突变谱在非小细胞肺癌和结直肠癌之间存在显著差异。

J Thorac Oncol. 2012 Apr;7(4):773-4; author reply 774. doi: 10.1097/JTO.0b013e318245a9c5.

8

Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice.晚期非小细胞肺癌临床实践中再次活检组织学肿瘤样本的意义。

Int J Clin Oncol. 2019 Jan;24(1):41-45. doi: 10.1007/s10147-018-1344-x. Epub 2018 Aug 29.

9

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌：欧洲肿瘤内科学会临床实践诊断、治疗及随访指南

Ann Oncol. 2010 May;21 Suppl 5:v116-9. doi: 10.1093/annonc/mdq189.

10

Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.晚期非小细胞肺癌的生物标志物检测：西班牙病理学会和西班牙医学肿瘤学会的全国共识

Clin Transl Oncol. 2015 Feb;17(2):103-12. doi: 10.1007/s12094-014-1248-9. Epub 2014 Oct 29.